The Craik Group at the University of Queensland stands at the forefront of peptide and protein science, pioneering the design, biosynthesis, and application of cyclic peptides for medicine and agriculture. Under the leadership of Professor David J. Craik, the lab explores the structural and functional diversity of naturally occurring peptide scaffolds—most notably the cyclotides—and transforms them into powerful molecular tools for drug discovery, crop protection, and molecular imaging.

With an energetic, multidisciplinary team spanning chemistry, biology, and biophysics, the Craik Group thrives on collaboration and innovation. Their research culture emphasizes creativity, rigor, and global connection, welcoming scientists from around the world to contribute to a shared vision of harnessing peptides to improve human health and sustainability. Whether in the lab, at conferences, or celebrating achievements by the pool, the Craik team embodies the spirit of curiosity and camaraderie that defines modern peptide science.

Meet Taylor Dill, a Fourth-year Ph.D. Candidate at the University of North Carolina at Chapel Hill, Eshelman School of Pharmacy, researching in the lab of President-Elect, Eileen J. Kennedy. Her work focuses on the design and characterization of constrained peptides to disrupt key protein-protein interactions in the WASF3 protein complex, which helps regulate migration and invasion as it relates to metastatic cancers. Taylor's work aims to serve as a foundation to increase the window for cancer treatment by downregulating the metastatic burden of various cancer types.

Outside of research, Taylor focuses on community outreach and undergraduate mentorship within the scientific community. She aims to foster a more inclusive and diverse research environment. In the future, Taylor plans to utilize the skills and knowledge she has gained throughout her academic career to bridge the gap in health disparities prevalent among underrepresented minorities in the clinic.

Peptides stand at the crossroads of chemistry and biology — molecules whose structures, modifications, and functions drive discovery from the lab bench to the clinic. Their ability to fold, interact, and transform makes them powerful tools for understanding biology and advancing therapeutic innovation.

Two leading ACS journals, Biochemistry and The Journal of Organic Chemistry, are collaborating on a joint Special Issue dedicated to the chemistry and biology of peptides. This issue will showcase the latest advances across synthesis, structure, function, and applications, while highlighting the growing impact of peptides in medicine and technology.

Researchers worldwide are invited to contribute original research, reviews, and perspectives that reflect the diversity and promise of peptide science. Manuscripts are welcome through December 31, 2025.